Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹286Cr
Finance & Investments - Others
Rev Gr TTM
Revenue Growth TTM
19.51%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ALMONDZ
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 41.3 | 11.7 | 57.6 | 58.9 | 70.5 | 69.1 | 46.5 | 10.3 | 16.2 | 6.7 | -0.8 | 56.3 |
| 24 | 15 | 19 | 26 | 41 | 26 | 30 | 29 | 48 | 26 | 29 | 41 |
Operating Profit Operating ProfitCr |
| 10.9 | 16.6 | 17.6 | 12.4 | 10.0 | 12.5 | 11.3 | 12.0 | 9.7 | 17.9 | 15.2 | 21.5 |
Other Income Other IncomeCr | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| 5 | 4 | 5 | 20 | 7 | 7 | 3 | 3 | 8 | 8 | 4 | 15 |
| 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 |
|
Growth YoY PAT Growth YoY% | 127.7 | -1.6 | 15.8 | 388.7 | 48.9 | 62.0 | -40.9 | -87.8 | 2.5 | 13.3 | 46.0 | 425.5 |
| 15.1 | 21.4 | 19.3 | 65.8 | 13.2 | 20.5 | 7.8 | 7.3 | 11.7 | 21.8 | 11.5 | 24.6 |
| 0.3 | 0.2 | 0.3 | 1.2 | 0.4 | 0.4 | 0.2 | 0.1 | 0.4 | 0.4 | 0.2 | 0.7 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| -34.8 | -24.4 | 10.2 | 39.9 | 4.2 | -18.7 | 1.3 | 12.0 | 10.6 | 44.5 | 36.2 | 13.7 |
| 48 | 47 | 50 | 68 | 70 | 59 | 54 | 60 | 67 | 101 | 133 | 143 |
Operating Profit Operating ProfitCr |
| 22.2 | -1.8 | 2.5 | 5.4 | 5.8 | 2.7 | 11.4 | 13.2 | 11.9 | 8.3 | 11.1 | 15.9 |
Other Income Other IncomeCr | 6 | 7 | 4 | 5 | 4 | 4 | 4 | 3 | 4 | 10 | 2 | 2 |
Interest Expense Interest ExpenseCr | 6 | 4 | 4 | 3 | 3 | 2 | 3 | 5 | 5 | 4 | 3 | 4 |
Depreciation DepreciationCr | 2 | 2 | 2 | 1 | 2 | 3 | 3 | 2 | 2 | 3 | 4 | 5 |
| 11 | 0 | 0 | 5 | 7 | 3 | 20 | 20 | 18 | 36 | 20 | 35 |
| 4 | 1 | 0 | 0 | 1 | -2 | 2 | 2 | 2 | 2 | 3 | 5 |
|
| 41.2 | -105.2 | -17.7 | 1,111.2 | 36.6 | -29.4 | 308.2 | 0.4 | -14.9 | 115.9 | -49.1 | 71.4 |
| 12.4 | -0.8 | -0.9 | 6.6 | 8.6 | 7.5 | 30.1 | 27.0 | 20.8 | 31.0 | 11.6 | 17.5 |
| 0.5 | 0.0 | 0.0 | 0.4 | 0.6 | 0.3 | 1.2 | 1.2 | 1.0 | 2.1 | 1.0 | 1.7 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 17 | 17 |
| 110 | 110 | 110 | 116 | 123 | 128 | 148 | 168 | 194 | 204 | 224 | 240 |
Current Liabilities Current LiabilitiesCr | 81 | 38 | 28 | 34 | 32 | 25 | 37 | 48 | 46 | 81 | 65 | |
Non Current Liabilities Non Current LiabilitiesCr | 18 | 16 | 15 | 22 | 19 | 19 | 13 | 20 | 15 | 16 | 45 | |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 160 | 108 | 98 | 110 | 88 | 85 | 86 | 105 | 115 | 169 | 184 | |
Non Current Assets Non Current AssetsCr | 66 | 71 | 71 | 77 | 102 | 103 | 127 | 147 | 156 | 148 | 167 | |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -18 | 32 | 12 | 26 | 11 | 15 | 1 | 10 | -14 | 35 | -9 |
Investing Cash Flow Investing Cash FlowCr | -8 | 4 | -1 | -1 | -4 | 1 | -2 | -4 | 2 | -33 | -13 |
Financing Cash Flow Financing Cash FlowCr | 31 | -42 | -13 | -18 | -13 | -9 | -3 | 1 | 7 | -6 | 33 |
|
Free Cash Flow Free Cash FlowCr | -19 | 32 | 11 | 23 | 9 | 14 | 0 | 5 | -16 | 29 | -14 |
| -232.4 | -8,211.9 | -2,683.8 | 560.2 | 170.6 | 321.4 | 3.0 | 54.1 | -87.0 | 102.9 | -54.4 |
CFO To EBITDA CFO To EBITDA% | -129.6 | -3,982.2 | 974.4 | 679.1 | 252.3 | 877.1 | 7.8 | 110.4 | -151.8 | 383.7 | -56.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 27 | 27 | 46 | 60 | 63 | 48 | 76 | 254 | 153 | 284 | 374 |
Price To Earnings Price To Earnings | 3.6 | 0.0 | 126.4 | 9.4 | 9.9 | 10.5 | 4.1 | 13.7 | 9.7 | 8.3 | 21.5 |
Price To Sales Price To Sales | 0.4 | 0.5 | 0.9 | 0.8 | 0.8 | 0.8 | 1.2 | 3.7 | 2.0 | 2.4 | 2.5 |
Price To Book Price To Book | 0.2 | 0.2 | 0.4 | 0.5 | 0.5 | 0.3 | 0.5 | 1.4 | 0.7 | 1.3 | 1.6 |
| 5.8 | -47.4 | 37.0 | 14.0 | 13.9 | 19.8 | 8.7 | 26.9 | 17.1 | 31.4 | 24.0 |
Profitability Ratios Profitability Ratios |
| 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| 22.2 | -1.8 | 2.5 | 5.4 | 5.8 | 2.7 | 11.4 | 13.2 | 11.9 | 8.3 | 11.1 |
| 12.4 | -0.8 | -0.9 | 6.6 | 8.6 | 7.5 | 30.1 | 27.0 | 20.8 | 31.0 | 11.6 |
| 8.6 | 2.9 | 2.3 | 5.1 | 6.2 | 3.2 | 12.8 | 12.3 | 9.8 | 16.8 | 8.1 |
| 6.0 | -0.3 | -0.4 | 3.6 | 4.6 | 3.1 | 11.3 | 10.1 | 7.5 | 15.5 | 7.2 |
| 3.4 | -0.2 | -0.3 | 2.5 | 3.4 | 2.4 | 8.7 | 7.4 | 5.8 | 10.7 | 4.9 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Almondz Global Securities Limited (AGSL), established in 1994, is a diversified Indian financial services and infrastructure advisory conglomerate with growing strategic interests in clean energy and healthcare. The company operates through multiple subsidiaries and joint ventures, offering integrated solutions across capital markets, infrastructure, wealth management, green technologies, and specialized healthcare services.
---
### **Strategic Business Segments**
#### **1. Green Biofuel & Sustainable Energy (Premier Green Innovations Pvt. Ltd – PGIPL)**
- **Ownership**: AGSL holds a 40.99% stake in **Premier Green Innovations Private Limited (PGIPL)**, a key joint venture driving its entry into the clean energy sector.
- **Core Operations**:
- One of the largest **zero liquid discharge (ZLD)** ethanol and **Extra Neutral Alcohol (ENA)** manufacturing facilities in Himachal Pradesh.
- Commissioned a **300 KLPD ethanol plant** in Himachal (FY2024–25) and is completing a **250 KLPD plant in Odisha**, positioning PGIPL as the region’s largest ethanol producer.
- Supplies ethanol to **Oil Marketing Companies (OMCs)** and global beverage giants like **Diageo, Seagram, and Pernod Ricard**, and ENA to pharma leaders including **ITC, Mankind, and Dr. Morepen**.
- Supports India’s **Ethanol Blending Programme (EBP)** with 2G ethanol from agricultural waste, aligning with national sustainability goals.
- **Technology & Innovation** (Sep 2025):
- Strategic alliance with **Entity 1 Value Emission Pvt. Ltd** to develop a **Waste-to-Value Added Products (VAP) platform** using **Microbial Electrochemical Cell (MECC)** technology.
- Converts agricultural and industrial waste into high-value chemicals: **ethyl acetate, acetic acid, and bio-hydrogen-based methanol**.
- Plans **Rs. 500 crore investment** over three years for a modular, scalable **alternative refinery**.
- First reactor, **RamCharan-MECC**, installed at Kangra site; trials to commence after financial closure.
#### **2. Infrastructure Advisory (Almondz Global Infra-Consultant Ltd – AGICL)**
- **Ownership**: Wholly owned subsidiary of AGSL, ISO-certified, and empaneled with over 30 government agencies.
- **Core Services** (Sep 2025):
- End-to-end advisory, engineering, and project management for **highways, airports, water systems, urban renewal, logistics, railways, and smart cities**.
- Active in both **PPP and government-led projects**, with an **order book exceeding Rs 350 crore (FY2025)**.
- Offers services from **project conception to O&M**, including risk assessment, safety audits, and regulatory compliance.
- **Technology & Strategy**:
- Employs **digital project management tools** and **AI-based due diligence frameworks** for complex projects in challenging terrains.
- Geographic expansion into **Northeast India** and diversification into **social infrastructure and renewable energy advisory**.
#### **3. Wealth Management & Capital Markets (Almondz Financial Services Ltd – AFSL)**
- **Ownership**: Wholly owned subsidiary, restructured in 2024 to consolidate AGSL’s merchant banking, PMS, and research arms.
- **Key Services**:
- Registered with **SEBI** as **Merchant Banker, Research Analyst, and PMS Provider** (Feb 2024).
- Offers **customized investment solutions** to HNIs, NRIs, family offices, and institutional clients.
- Products include **PMS, AIFs, mutual funds, insurance, equities, derivatives, ETFs, and estate planning**.
- **Technology-Driven Advisory**:
- AI-powered **goal-based planning tools**, real-time portfolio tracking, and thematic investing (including **ESG-screened portfolios**).
- Integrated **mobile-first platform** with biometric login, voice search, and paperless e-KYC.
- **Distribution Expansion**:
- Penetrating **Tier II/III cities** via digital hubs and affiliate networks to enhance financial inclusion.
- **Supporting Infrastructure**:
- **Real-time trading systems**, cloud-based reporting, omnichannel customer support, and 24x7 chatbots.
- **Depository services** via NSDL/CDSL with automated pledging, corporate action management, and secure demat operations.
- **Research Edge**:
- Publishes actionable insights on **equity strategies, sectoral trends, IPOs, and fund performance**, strengthening advisory credibility.
- Synergies with **broking and depository services** enable an **integrated capital markets ecosystem**.
#### **4. Broking & Investment Access**
- Full-suite access to:
- **Equities, derivatives, mutual funds, ETFs, IPOs, fixed-income securities, and commodities**.
- Platform Features:
- Web and **mobile trading apps**, competitive brokerage, SIP integration, and real-time analytics.
- Robust customer onboarding and service via **digital workflows and cloud infrastructure**.
#### **5. Healthcare (Skiffle Healthcare Services Ltd – SHSL)**
- **Ownership**: Wholly owned subsidiary, established in 2012.
- **Operations**:
- Operates **four super-specialty eye care centers** under **‘Itek Vision Centre’** in Delhi & NCR.
- Services include **cataract, glaucoma, LASIK, cornea, retina, pediatric, and neuro-ophthalmology**, using advanced diagnostic and surgical technology.
- Focus on **ethical practice, quality care, and patient experience**.
#### **6. Other Subsidiaries & Associates**
- **Anemone Holding Pvt. Ltd**: Holding company for investments in equity, preference shares, and bonds. Offices in Mumbai (registered) and Delhi (corporate).
- **Avonmore Developer Pvt. Ltd**: Real estate developer engaged in residential, commercial, industrial, and infrastructure projects.
- **Apricot Infosoft Pvt. Ltd**: IT services provider (software, digital marketing, web services). Currently **non-revenue generating**.
- **Almondz Insolvency Resolutions Services Pvt. Ltd**: Associate company (33% stake) focused on **insolvency and resolution services** under IBC.
---
### **Financial Performance & Structure (as of Sep 2025)**
- **Revenue Segments**:
- **Consultancy & Advisory**: ₹12,721 million (primary revenue driver).
- **Wealth Advisory/Broking**: ₹2,029 million.
- **Profitability**:
- **Consolidated Profit Before Tax**: ₹1,495 million.
- **Segment Profit (Consultancy & Advisory)**: ₹1,585 million (core profit engine).
- **Asset Base**:
- **Consultancy & Advisory**: ₹10,349 million.
- **Others (including holdings & real estate)**: ₹8,921 million.